Key facts
- This page summarizes Albert Seymour's Form 4 filing for Homology Medicines, Inc. (QTTB).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 28 Feb 2022, 15:05.
Albert Seymour - 24 Feb 2022 Form 4 Insider Report for Homology Medicines, Inc. (QTTB)
- Reporting relationship
- Chief Scientific Officer
- Issuer ticker
- QTTB
- Reported as of
- 24 Feb 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 28 Feb 2022, 15:05:20 UTC
- Prior SEC filing
- 12 Jan 2022
- Next SEC filing
- 21 Apr 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ W. Bradford Smith, Attorney-in-Fact for Albert Seymour
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Albert Seymour filed Form 4 for Homology Medicines, Inc. (QTTB) on 28 Feb 2022.
Change
- Previous filing in this sequence was filed on 12 Jan 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
FIXX
transaction
Derivative
Employee Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +128,000
- Change %
- Price
- $0.000000
- Shares after
- 128,000
- Date
- 24 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 128,000
- Exercise price
- $2.71
- Footnotes
- F1
FIXX
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +21,000
- Change %
- Price
- $0.000000
- Shares after
- 21,000
- Date
- 24 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 21,000
- Exercise price
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The option vests in 48 substantially equal monthly installments on the first day of each calendar month following January 1, 2022.
Footnote F2
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.
Footnote F3
The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025.